The present invention provides a novel retinoic acid metabolizing
cytochrome P450, P450RAI-3, that is predominantly expressed in the
adrenal gland. Methods for and uses of the new polynucleotide,
polypeptide, fragments thereof and modulators thereof, include the
treatment of cancer.